Immunohistochemical mismatch repair proteins expression in colorectal cancer

Applied Immunohistochemistry and Molecular Morphology

Volumn 14, Issue 1, 2006, Pages 42-45

  Valentini, Anna Maria ^a   Armentano, Raffaele ^a   Pirrelli, Michele ^a   Gentile, Mattia ^a   Caruso, Maria Lucia ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Mismatch repair protein; MLH1; MSH2

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC TEST; EVALUATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MISMATCH REPAIR; MOLECULAR DYNAMICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; COLORECTAL NEOPLASMS; DNA REPAIR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 33645149571     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000155193.92167.6a     Document Type: Article

References (27)

1. Wheeler JM, Bodmer WF, Mortensen NJ. DNA mismatch repair genes and colorectal cancer. Gut. 2000;47:148-153.
2. Fishel R. Signaling mismatch repair in cancer. Nat Med. 1999;5:1239-1241.
3. Rampino N, Yamamoto H, Ionov Y, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science. 1997;275:967-969.
4. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science. 1993;260:812-816.
5. Aaltonen LA, Peltomaki P, Mecklin JP, et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res. 1994;54:1645-1648.
6. Elsaleh H, Powell B, Soontrapornchai P, et al. P53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes-C colon carcinoma. Oncology. 2000;58:52-59.
7. Samowitz WS, Curtin K, Ma K-M, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomark Prev. 2001;10:917-923.
8. Valentini AM, Renna L, Armentano R, et al. Mismatch repair, p53 and β-catenin proteins in colorectal cancer. Anticancer Res. 2002;22:2083-2088.
9. Chapusot C, Martin L, Bouvier AM, et al. Microsatellite instability and intratumoral heterogeneity in 100 right-sided sporadic colon carcinomas. Br J Cancer. 2002;87:400-404.
10. Jass JR, Ajioka Y, Allen JP, et al. Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology. 1996; 28:543-548.
11. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familiar predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
12. Bellacosa A, Cicchillitti L, Schepis F, et al. Med 1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc Natl Acad Sci USA. 1999;96:3969-3974.
13. Manavis JU, Gilham P, Davies R. The immunohistochemical detection of mismatch repair gene proteins (MLH1, MSH2, MSH6, and PMS2): practical aspects in antigen retrieval and biotin blocking protocols. Appl Immunohistochem Mol Morphol. 2003;11:73-77.
14. Thibodeau SN, French AJ, Cunningham JM, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res. 1998;58:1713-1718.
15. Gafà R, Maestri I, Matteuzzi M, et al. Sporadic colorectal adenocarcinoma with high-frequency microsatellite instability. Pathobiologic features, hMLH1 and hMSH2 expression, and clinical outcome. Cancer. 2000; 89:2025-2037.
16. Chung DC, Rustgi AK. DNA mismatch repair and cancer. Gastroenterology. 1995;105:1685-1699.
17. Lanza G, Gafà R, Maestri I, et al. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. Mod Pathol. 2002;15:741-749.
18. Cawkwell L, Gray S, Murgatroyd H, et al. Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut. 1999;45:409-415.
19. Stone JG, Robertson D, Houlston RS. Immunohistochemistry for MSH2 and MHL1: a method for identifying mismatch repair deficient colorectal cancer. J Clin Pathol. 2001;54:484-487.
20. Monzon F, Kovatich A, Barussevicius A, et al. Effect of fixation time on the immunohistochemical detection of HMLH1 and HMSH2 in paraffinembedded tissue. Mod Pathol. 1999;12:193A.
21. Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002;15:897-899.
22. Kim H, Piao Z, Kim JW, et al. Expression of hMSH2 and hMLH1 in colorectal carcinomas with microsatellite instability. Pathol Res Pract. 1998;194:3-9.
23. Paraf F, Gilquin M, Longy M, et al. MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients. Histopathology. 2001;39:250-258.
24. Ward R, Meagher A, Tomlinson I, et al. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut. 2001;48:821-829.
25. Marcus VA, Madlensky L, Gryfe R, et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol. 1999;23:1248-1255.
26. Jass JR, Do KA, Simms LA. Morphology of sporadic colorectal cancer with DNA replication errors. Gut. 1998;42:673-679.
27. Feeley KM, Fullard JF, Henegham MA, et al. Microsatellite instability in sporadic colorectal carcinomas is not an indicator of prognosis. J Pathol. 1999;188:14-17.